| Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications S Facchin, L Bertin, E Bonazzi, G Lorenzon, C De Barba, B Barberio, ... Life 14 (5), 559, 2024 | 46 | 2024 |
| The Role of the FODMAP Diet in IBS L Bertin, M Zanconato, M Crepaldi, G Marasco, C Cremon, G Barbara, ... Nutrients 16 (3), 370, 2024 | 19 | 2024 |
| Myths and facts about food intolerance: a narrative review F Zingone, L Bertin, D Maniero, M Palo, G Lorenzon, B Barberio, C Ciacci, ... Nutrients 15 (23), 4969, 2023 | 17 | 2023 |
| Extraintestinal cancers in inflammatory bowel disease: A literature review A Massano, L Bertin, F Zingone, A Buda, P Visaggi, L Bertani, N de Bortoli, ... Cancers 15 (15), 3824, 2023 | 8 | 2023 |
| Efficacy and safety of oral beclomethasone dipropionate and budesonide MMX versus 5-aminosalicylates or placebo in ulcerative colitis: a systematic review and … B Barberio, I Marsilio, A Buda, L Bertin, G Semprucci, A Zanini, M Crepaldi, ... Therapeutic Advances in Gastroenterology 16, 17562848231188549, 2023 | 5 | 2023 |
| Pharmacological management of gastro-esophageal reflux disease: state of the art in 2024 P Visaggi, L Bertin, A Pasta, F Calabrese, M Ghisa, E Marabotto, ... Expert Opinion on Pharmacotherapy 25 (15), 2077-2088, 2024 | 3 | 2024 |
| Emerging Pharmaceutical Therapies to Address the Inadequacy of a Gluten-Free Diet for Celiac Disease M Crepaldi, M Palo, D Maniero, L Bertin, EV Savarino, RP Anderson, ... Pharmaceuticals 17 (1), 4, 2023 | 2 | 2023 |
| Refractory Crohn’s disease: perspectives, unmet needs and innovations L Bertin, M Crepaldi, M Zanconato, G Lorenzon, D Maniero, C De Barba, ... Clinical and Experimental Gastroenterology, 261-315, 2024 | 1 | 2024 |
| Primary sclerosing cholangitis and inflammatory bowel disease: a complicated yet unique relationship. M Peviani, N Cazzagon, M Gambato, L Bertin, F Zingone, EV Savarino, ... Minerva Gastroenterology, 2024 | 1 | 2024 |
| P0667 Therapeutic Optimization of Biologic Therapy in Ulcerative Colitis: A Retrospective Analysis of Endoscopic and Biomarker Outcomes C Bezzio, L Bertin, LG Ranucci, G Marconcini, A Busacca, A Dal Buono, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1305-i1306, 2025 | | 2025 |
| P0758 Efficacy of advanced therapies for the treatment of refractory pouchitis in patients with ileal-pouch anastomosis (IPAA): a multicentre Italian real-life experience AM Carvalhas Gabrielli, R Cannatelli, F Ferretti, S Carmagnola, ... Journal of Crohn's and Colitis 19 (Supplement_1), i1466-i1467, 2025 | | 2025 |
| P0662 Comparative effectiveness and safety of upadacitinib, tofacitinib, and filgotinib in patients with Ulcerative Colitis: analysis of whole and propensity score-matched data L Bertin, D Scarabello, F Zingone, EV Savarino, B Barberio Journal of Crohn's and Colitis 19 (Supplement_1), i1294-i1295, 2025 | | 2025 |
| Topical Protection of Esophageal Mucosa as a New Treatment of GERD V Savarino, P Visaggi, E Marabotto, L Bertin, A Pasta, F Calabrese, ... Journal of Clinical Gastroenterology, 10.1097, 2025 | | 2025 |
| Risk Factors and Postoperative Outcomes in Pouchitis Following Restorative Proctocolectomy: An 18-Year Single-Center Study L Bertin, M Nasrallah, C Redavid, E Bonazzi, D Maniero, G Lorenzon, ... Gastroenterology Insights 15 (4), 1075-1092, 2024 | | 2024 |
| Advancing therapeutic frontiers: a pipeline of novel drugs for luminal and perianal Crohn's disease management L Bertin, M Crepaldi, M Zanconato, G Lorenzon, D Maniero, C de Barba, ... Therapeutic Advances in Gastroenterology 17, 17562848241303651, 2024 | | 2024 |
| Evaluating Vonoprazan for the treatment of erosive GERD and heartburn associated with GERD in adults E Marabotto, F Calabrese, A Pasta, P Visaggi, N de Bortoli, A Mari, ... Expert Opinion on Pharmacotherapy 25 (17), 2319-2325, 2024 | | 2024 |
| The Esophageal Microbiota in Esophageal Health and Disease E Bonazzi, G Lorenzon, D Maniero, C De Barba, L Bertin, B Barberio, ... Gastroenterology Insights 15 (4), 998-1013, 2024 | | 2024 |
| Upper gastrointestinal Crohn's disease: What are we talking about? L Bertin, B Barberio, EV Savarino United European Gastroenterology Journal 12 (10), 1352, 2024 | | 2024 |
| Comparing Point-of-Care Technology to ELISA Testing for Infliximab and Adalimumab Levels in Adult Inflammatory Bowel Disease Patients: A Prospective Pilot Study E Bonazzi, D Maniero, G Lorenzon, L Bertin, K Bray, B Bahur, B Barberio, ... Diagnostics 14 (19), 2140, 2024 | | 2024 |
| Prevalence of Sexual Dysfunction in Inflammatory Bowel Disease: Systematic Review and Meta-analysis OM Nardone, G Calabrese, L Bertin, AC Ford, F Castiglione, F Zingone, ... Journal of Crohn's and Colitis, jjae133, 2024 | | 2024 |
